Lateral pelvic lymphadenectomy for low rectal cancer: a META-analysis of recurrence rates

go back to reference Rawla P, Sunkara T, Barsouk A (2019) Epidemiology of colorectal cancer: incidence, mortality, survival and risk factors. Prz Gastroenterol 14(2):89–103PubMedPubMedCentral Rawla P, Sunkara T, Barsouk A (2019) Epidemiology of colorectal cancer: incidence, mortality, survival and risk factors. Prz Gastroenterol 14(2):89–103PubMedPubMedCentral

go back to reference Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal Cancer. Lancet 394:167–180 Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal Cancer. Lancet 394:167–180

go back to reference De Wilt JHW, Vermaas M, Ferenschild FTJ, Verhoef C (2007) Management of locally advanced primary and recurrent rectal cancer. Clin Colon Rectal Surg 20(3):255–264PubMedPubMedCentral De Wilt JHW, Vermaas M, Ferenschild FTJ, Verhoef C (2007) Management of locally advanced primary and recurrent rectal cancer. Clin Colon Rectal Surg 20(3):255–264PubMedPubMedCentral

go back to reference Beyond TME Collaborative (2013) Beyond TME collaborative consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):1009–1014 Beyond TME Collaborative (2013) Beyond TME collaborative consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):1009–1014

go back to reference Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T (2002) Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 45:1078–1084PubMed Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T (2002) Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 45:1078–1084PubMed

go back to reference Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J (2016) Locally advanced rectal cancer: management challenges. Onco Targets Ther 9:6265–6272PubMedPubMedCentral Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J (2016) Locally advanced rectal cancer: management challenges. Onco Targets Ther 9:6265–6272PubMedPubMedCentral

go back to reference Nielsen M, Rasmussen P, Lindegaard J et al (2012) A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Color Dis 14:1076–1083 Nielsen M, Rasmussen P, Lindegaard J et al (2012) A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Color Dis 14:1076–1083

go back to reference Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, Van Krieken JH, Leer JW, Van de Velde CJ (2001) Dutch colorectal cancer group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646PubMed Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, Van Krieken JH, Leer JW, Van de Velde CJ (2001) Dutch colorectal cancer group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646PubMed

go back to reference Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987 Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987

go back to reference Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1:1479–1482PubMed Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1:1479–1482PubMed

go back to reference Platell CF (2007) Changing patterns of recurrence after treatment for colorectal cancer. Int J Color Dis 22(10):1223–1231 Platell CF (2007) Changing patterns of recurrence after treatment for colorectal cancer. Int J Color Dis 22(10):1223–1231

go back to reference Fearnhead NS, Acheson AG, Brown SR, Hancock L et al (2020) The ACPGBI recommends pause for reflection on transanal total mesorectal excision. Colorectal Dis 22(7):745–748PubMedPubMedCentral Fearnhead NS, Acheson AG, Brown SR, Hancock L et al (2020) The ACPGBI recommends pause for reflection on transanal total mesorectal excision. Colorectal Dis 22(7):745–748PubMedPubMedCentral

go back to reference Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44(9):1274–1280PubMed Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44(9):1274–1280PubMed

go back to reference Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10:1053–1062PubMed Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10:1053–1062PubMed

go back to reference Hashiguchi Y, Muro K, Saito Y et al (2019) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1):1–42PubMedPubMedCentral Hashiguchi Y, Muro K, Saito Y et al (2019) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1):1–42PubMedPubMedCentral

go back to reference Ueno H, Mochizuki H, Hashiguchi Y, Hase K (2001) Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Surg 234(2):190–197PubMedPubMedCentral Ueno H, Mochizuki H, Hashiguchi Y, Hase K (2001) Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Surg 234(2):190–197PubMedPubMedCentral

go back to reference Kim TH, Jeong SY, Choi DH et al (2019) Oncological outcomes of patients with locally advanced rectal cancer and lateral pelvic lymph node involvement. J Gastrointest Surg 23:1454–1460 Kim TH, Jeong SY, Choi DH et al (2019) Oncological outcomes of patients with locally advanced rectal cancer and lateral pelvic lymph node involvement. J Gastrointest Surg 23:1454–1460

go back to reference Yamada K, Ishizawa T, Niwa K, Chuman Y, Akiba S, Aikou T (2001) Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 88(7):988–993PubMed Yamada K, Ishizawa T, Niwa K, Chuman Y, Akiba S, Aikou T (2001) Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 88(7):988–993PubMed

go back to reference Tanis PJ, Doeksen A, van Lanschot JJ (2013) Intentionally curative treatment of locally recurrent rectal cancer: a systematic review. Can J Surg 56:135–144PubMedPubMedCentral Tanis PJ, Doeksen A, van Lanschot JJ (2013) Intentionally curative treatment of locally recurrent rectal cancer: a systematic review. Can J Surg 56:135–144PubMedPubMedCentral

go back to reference Camilleri-Brennan J, Steele RJ (2001) The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 27(4):349–353PubMed Camilleri-Brennan J, Steele RJ (2001) The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 27(4):349–353PubMed

go back to reference Akasu T, Sugihara K, Moriya Y (2009) Male urinary and sexual functions after mesorectal excisions alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 16(10):2779–2786PubMed Akasu T, Sugihara K, Moriya Y (2009) Male urinary and sexual functions after mesorectal excisions alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 16(10):2779–2786PubMed

go back to reference Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K, Japanese Society for Cancer of the Colon and Rectum (2012) Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg 255(6):1129–1134PubMed Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K, Japanese Society for Cancer of the Colon and Rectum (2012) Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg 255(6):1129–1134PubMed

go back to reference Hojo K, Sawada T, Moriya Y (1989) An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum 32(2):128–133PubMed Hojo K, Sawada T, Moriya Y (1989) An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum 32(2):128–133PubMed

go back to reference Moriya Y, Sugihara K, Akasu T, Fujita S (1997) Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21(7):728–732PubMed Moriya Y, Sugihara K, Akasu T, Fujita S (1997) Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21(7):728–732PubMed

go back to reference Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49:1663–1672PubMed Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49:1663–1672PubMed

go back to reference Akasu T, Sugihara K, Moriya Y (2009) Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 16(10):2779–2786PubMed Akasu T, Sugihara K, Moriya Y (2009) Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 16(10):2779–2786PubMed

go back to reference Tokuhara K, Hishikawa H, Yoshida T, Ueyama Y, Yoshioka K, Sekimoto M (2020) Laparoscopic versus open selective lateral pelvic lymph node dissection following total mesorectal excision for locally advanced low rectal cancer. Int J Color Dis 35(7):1301–1309 Tokuhara K, Hishikawa H, Yoshida T, Ueyama Y, Yoshioka K, Sekimoto M (2020) Laparoscopic versus open selective lateral pelvic lymph node dissection following total mesorectal excision for locally advanced low rectal cancer. Int J Color Dis 35(7):1301–1309

go back to reference Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700PubMedPubMedCentral Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700PubMedPubMedCentral

go back to reference Hozo SP, Djulbegovic G, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13PubMedPubMedCentral Hozo SP, Djulbegovic G, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13PubMedPubMedCentral

go back to reference Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003 Sep) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712–716PubMed Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003 Sep) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712–716PubMed

go back to reference Esnaola NF, Cantor SB, Johnson ML, Mirza AN, Miller AR, Curley SA, Crane CH, Cleeland CS, Janjan NA, Skibber JM (2002) Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 20(21):4361–4367PubMed Esnaola NF, Cantor SB, Johnson ML, Mirza AN, Miller AR, Curley SA, Crane CH, Cleeland CS, Janjan NA, Skibber JM (2002) Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 20(21):4361–4367PubMed

go back to reference Detering R, Karthaus EG, Borstlap WAA, Marijnen CAM, van de Velde CJH, Bemelman WA, Beets GL, Tanis PJ, Aalbers AGJ, Aalbers AGJ, Acherman Y, Algie GD, Alting von Geusau B, Amelung F, Aukema TS, Bakker IS, Bartels SA, Basha S, Bastiaansen AJNM, Belgers E, Bleeker W, Blok J, Bosker RJI, Bosmans JW, Boute MC, Bouvy ND, Bouwman H, Brandt-Kerkhof A, Brinkman DJ, Bruin S, Bruns ERJ, Burbach JPM, Burger JWA, Buskens CJ, Clermonts S, Coene PPLO, Compaan C, Consten ECJ, Darbyshire T, de Mik SML, de Graaf EJR, de Groot I, tot Nederveen Cappel RJV, de Wilt JHW, van der Wolde J, Boer FC, Dekker JWT, Demirkiran A, Derkx-Hendriksen M, Dijkstra FR, van Duijvendijk P, Dunker MS, Eijsbouts QE, Fabry H, Ferenschild F, Foppen JW, Furnee EJB, Gerhards MF, Gerven P, Gooszen JAH, Govaert JA, van Grevenstein WMU, Haen R, Harlaar JJ, van der Harst E, Havenga K, Heemskerk J, Heeren JF, Heijnen B, Heres P, Hoff C, Hogendoorn W, Hoogland P, Huijbers A, Janssen P, Jongen AC, Jonker FH, Karthaus EG, Keijzer A, Ketel JMA, Klaase J, Kloppenberg FWH, Kool ME, Kortekaas R, Kruyt PM, Kuiper JT, Lamme B, Lange JF, Lettinga T, Lips DJ, Logeman F, Lutke Holzik MF, Madsen E, Mamound A, Marres CC, Masselink I, Meerdink M, Menon AG, Mieog JS, Mierlo D, Musters GD, Nieuwenhuijzen GAP, Neijenhuis PA, Nonner J, Oostdijk M, Oosterling SJ, Paul PMP, Peeters KCMJ, Pereboom ITA, Polat F, Poortman P, Raber M, Reiber BMM, Renger RJ, van Rossem CC, Rutten HJ, Rutten A, Schaapman R, Scheer M, Schoonderwoerd L, Schouten N, Schreuder AM, Schreurs WH, Simkens GA, Slooter GD, Sluijmer HCE, Smakman N, Smeenk R, Snijders HS, Sonneveld DJA, Spaansen B, Bilgen EJS, Steller E, Steup WH, Steur C, Stortelder E, Straatman J, Swank HA, Sietses C, Groen HA, Hoeve HG, Riele WW, Thorensen IM, Tip-Pluijm B, Toorenvliet BR, Tseng L, Tuynman JB, van Bastelaar J, van Beek SC, van de Ven AWH, van de Weijer MAJ, van den Berg C, van den Bosch I, van der Bilt JDW, van der Hagen SJ, van der Hul R, van der Schelling G, van der Spek A, van der Wielen N, van Duyn E, van Eekelen C, van Essen JA, van Gangelt K, van Geloven AAW, van Kessel C, van Loon YT, van Rijswijk A, van Rooijen SJ, van Sprundel T, van Steensel L, van Tets WF, van Westreenen HL, Veltkamp S, Verhaak T, Verheijen PM, Versluis-Ossenwaarde L, Vijfhuize S, Vles WJ, Voeten SC, Vogelaar FJ, Vrijland WW, Westerduin E, Westerterp ME, Wetzel M, Wevers KP, Wiering B, Witjes CDM, Wouters MW, Yauw STK, van der Zaag ES, Zeestraten EC, Zimmerman DDE, Zwieten T (2019) Treatment and survival of locally recurrent rectal cancer: a cross-sectional population study 15 years after the Dutch TME trial. Eur J Surg Oncol 45(11):2059–2069PubMed Detering R, Karthaus EG, Borstlap WAA, Marijnen CAM, van de Velde CJH, Bemelman WA, Beets GL, Tanis PJ, Aalbers AGJ, Aalbers AGJ, Acherman Y, Algie GD, Alting von Geusau B, Amelung F, Aukema TS, Bakker IS, Bartels SA, Basha S, Bastiaansen AJNM, Belgers E, Bleeker W, Blok J, Bosker RJI, Bosmans JW, Boute MC, Bouvy ND, Bouwman H, Brandt-Kerkhof A, Brinkman DJ, Bruin S, Bruns ERJ, Burbach JPM, Burger JWA, Buskens CJ, Clermonts S, Coene PPLO, Compaan C, Consten ECJ, Darbyshire T, de Mik SML, de Graaf EJR, de Groot I, tot Nederveen Cappel RJV, de Wilt JHW, van der Wolde J, Boer FC, Dekker JWT, Demirkiran A, Derkx-Hendriksen M, Dijkstra FR, van Duijvendijk P, Dunker MS, Eijsbouts QE, Fabry H, Ferenschild F, Foppen JW, Furnee EJB, Gerhards MF, Gerven P, Gooszen JAH, Govaert JA, van Grevenstein WMU, Haen R, Harlaar JJ, van der Harst E, Havenga K, Heemskerk J, Heeren JF, Heijnen B, Heres P, Hoff C, Hogendoorn W, Hoogland P, Huijbers A, Janssen P, Jongen AC, Jonker FH, Karthaus EG, Keijzer A, Ketel JMA, Klaase J, Kloppenberg FWH, Kool ME, Kortekaas R, Kruyt PM, Kuiper JT, Lamme B, Lange JF, Lettinga T, Lips DJ, Logeman F, Lutke Holzik MF, Madsen E, Mamound A, Marres CC, Masselink I, Meerdink M, Menon AG, Mieog JS, Mierlo D, Musters GD, Nieuwenhuijzen GAP, Neijenhuis PA, Nonner J, Oostdijk M, Oosterling SJ, Paul PMP, Peeters KCMJ, Pereboom ITA, Polat F, Poortman P, Raber M, Reiber BMM, Renger RJ, van Rossem CC, Rutten HJ, Rutten A, Schaapman R, Scheer M, Schoonderwoerd L, Schouten N, Schreuder AM, Schreurs WH, Simkens GA, Slooter GD, Sluijmer HCE, Smakman N, Smeenk R, Snijders HS, Sonneveld DJA, Spaansen B, Bilgen EJS, Steller E, Steup WH, Steur C, Stortelder E, Straatman J, Swank HA, Sietses C, Groen HA, Hoeve HG, Riele WW, Thorensen IM, Tip-Pluijm B, Toorenvliet BR, Tseng L, Tuynman JB, van Bastelaar J, van Beek SC, van de Ven AWH, van de Weijer MAJ, van den Berg C, van den Bosch I, van der Bilt JDW, van der Hagen SJ, van der Hul R, van der Schelling G, van der Spek A, van der Wielen N, van Duyn E, van Eekelen C, van Essen JA, van Gangelt K, van Geloven AAW, van Kessel C, van Loon YT, van Rijswijk A, van Rooijen SJ, van Sprundel T, van Steensel L, van Tets WF, van Westreenen HL, Veltkamp S, Verhaak T, Verheijen PM, Versluis-Ossenwaarde L, Vijfhuize S, Vles WJ, Voeten SC, Vogelaar FJ, Vrijland WW, Westerduin E, Westerterp ME, Wetzel M, Wevers KP, Wiering B, Witjes CDM, Wouters MW, Yauw STK, van der Zaag ES, Zeestraten EC, Zimmerman DDE, Zwieten T (2019) Treatment and survival of locally recurrent rectal cancer: a cross-sectional population study 15 years after the Dutch TME trial. Eur J Surg Oncol 45(11):2059–2069PubMed

go back to reference Yancy Nou Y, Habiba H, Chang GJ, Rodriguez-Bigas MA, Skibber JM (2011) Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol 18(4):989–996 Yancy Nou Y, Habiba H, Chang GJ, Rodriguez-Bigas MA, Skibber JM (2011) Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol 18(4):989–996

go back to reference Vermaas M, Ferenschild FTJ, Verhoef C, Nuyttens JJME, Marinelli AWKS, Wiggers T, Kirkels WJ, Eggermont AMM, de Wilt JHW (2007) Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 33(4):452–458PubMed Vermaas M, Ferenschild FTJ, Verhoef C, Nuyttens JJME, Marinelli AWKS, Wiggers T, Kirkels WJ, Eggermont AMM, de Wilt JHW (2007) Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 33(4):452–458PubMed

go back to reference Ogunbiyi OA, McKenna K, Birnbaum EH, Fleshman JW, Kodner IJ (1997) Aggressive surgical management of recurrent rectal cancer – is it worthwhile? Dis Colon Rectum 40:150–155PubMed Ogunbiyi OA, McKenna K, Birnbaum EH, Fleshman JW, Kodner IJ (1997) Aggressive surgical management of recurrent rectal cancer – is it worthwhile? Dis Colon Rectum 40:150–155PubMed

go back to reference Kusters M, Beets GL, Van de Velde CJH, Beets-Tan RGH, Marijnen CAM, Rutten HJT, Putter H, Moriya Y (2009) A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on patterns of local recurrence. Ann Surg 249(2):229–235PubMed Kusters M, Beets GL, Van de Velde CJH, Beets-Tan RGH, Marijnen CAM, Rutten HJT, Putter H, Moriya Y (2009) A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on patterns of local recurrence. Ann Surg 249(2):229–235PubMed

go back to reference Mori T, Takahashi K, Yasuno M (1998) Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbeck's Arch Surg 383(6):409–415 Mori T, Takahashi K, Yasuno M (1998) Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbeck's Arch Surg 383(6):409–415

go back to reference Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T (2005) Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 92(6):756–763PubMed Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T (2005) Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 92(6):756–763PubMed

go back to reference De Pablos JO, Mayol J (2019) Controversies in the management of lateral pelvic lymph nodes in patients with advanced rectal cancer: east or west? Front Surg 6:79 De Pablos JO, Mayol J (2019) Controversies in the management of lateral pelvic lymph nodes in patients with advanced rectal cancer: east or west? Front Surg 6:79

go back to reference Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S (2012) Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev 3:CD004078 Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S (2012) Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev 3:CD004078

go back to reference Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, Chang HJ, Lim SB, Choi HS, Park JG (2008) Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 15:729–737PubMed Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, Chang HJ, Lim SB, Choi HS, Park JG (2008) Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 15:729–737PubMed

go back to reference Ogawa S, Hida J, Ike H, Kinugasa T, Ota M, Shinto E, Itabashi M, Okamoto T, Sugihara K (2016) The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the lymph node Committee of Japanese Society for Cancer of the Colon and Rectum. Int J Color Dis 31:1719–1728 Ogawa S, Hida J, Ike H, Kinugasa T, Ota M, Shinto E, Itabashi M, Okamoto T, Sugihara K (2016) The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the lymph node Committee of Japanese Society for Cancer of the Colon and Rectum. Int J Color Dis 31:1719–1728

go back to reference Oh HK, Kang SB, Lee SM, Lee SY, Ihn MH, Kim DW, Park JH, Kim YH, Lee KH, Kim JS, Kim JW, Kim JH, Chang TY, Park SC, Sohn DK, Oh JH, Park JW, Ryoo SB, Jeong SY, Park KJ (2014) Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol 21(7):2280–2287PubMed Oh HK, Kang SB, Lee SM, Lee SY, Ihn MH, Kim DW, Park JH, Kim YH, Lee KH, Kim JS, Kim JW, Kim JH, Chang TY, Park SC, Sohn DK, Oh JH, Park JW, Ryoo SB, Jeong SY, Park KJ (2014) Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol 21(7):2280–2287PubMed

go back to reference Kim MJ, Chan Park S, Kim TH, Kim DY, Kim SY, Baek JY, Chang HJ, Park JW, Oh JH (2016) Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node? Surg. 160(2):366–376 Kim MJ, Chan Park S, Kim TH, Kim DY, Kim SY, Baek JY, Chang HJ, Park JW, Oh JH (2016) Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node? Surg. 160(2):366–376

go back to reference Yang X, Hu T, Gu C, Yang S, Jiang D, Deng X, Wang Z, Zhou Z (2019) The prognostic significance of isolated tumor cells detected within lateral lymph nodes in rectal cancer patients after laparoscopic lateral lymph node dissection. J Laparoendosc Adv Surg Tech A 29:1462–1468PubMed Yang X, Hu T, Gu C, Yang S, Jiang D, Deng X, Wang Z, Zhou Z (2019) The prognostic significance of isolated tumor cells detected within lateral lymph nodes in rectal cancer patients after laparoscopic lateral lymph node dissection. J Laparoendosc Adv Surg Tech A 29:1462–1468PubMed